1. |
Pantelias K. Vascular access today. World J Nephrol, 2012, 1(3): 69-78.
|
2. |
Donati G, Colì L, Cianciolo G, et al. Thrombosis of tunneled-cuffed hemodialysis catheters: treatment with high-dose urokinase lock therapy. Artif Organs, 2012, 36(1): 21-28.
|
3. |
Bonkain F, Van Hulle F, Janssens P, et al. Urokinase-containing locking solution in the prevention of dialysis catheter dysfunction: a double blind randomized controlled trial. J Vasc Access, 2017, 18(5): 436-442.
|
4. |
MacRae JM, Ahmed A, Johnson N, et al. Central vein stenosis:a common problem in patients on hemodialysis. ASAIO J, 2005, 51(1): 77-81.
|
5. |
Gunawansa N, Sudusinghe DH, Wijayaratne DR. Hemodialysis catheter-related central venous thrombosis: clinical approach to evaluation and management. Ann Vasc Surg, 2018, 51: 298-305.
|
6. |
Leblanc M, Bosc JY, Paganini EP, et al. Central venous dialysis catheter dysfunction. Adv Ren Replace Ther, 1997, 4(4): 377-389.
|
7. |
黄琪, 孙雪峰, 林洪丽, 等. 维持性血液透析血管通路抗凝治疗多中心流行病学研究. 中国实用内科杂志, 2014, 34(6): 579-583.
|
8. |
Han X, Yang X, Huang B, et al. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis. Clin Nephrol, 2016, 86(7): 1-8.
|
9. |
Davenport A. The rationale for the use of low molecular weight heparin for hemodialysis treatments. Hemodial Int, 2013, 17(Suppl 1): S28-S32.
|
10. |
Lim W, Cook DJ, Crowther MA. Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials. J Am Soc Nephrol, 2004, 15(12): 3192-3206.
|
11. |
陈香美. 血液净化标准操作规程. 北京: 人民军医出版社, 2011: 46.
|
12. |
Stefoni S, Cianciolo G, Donati G, et al. Standard heparin versus low-molecular-weight heparin. A medium-term comparison in hemodialysis. Nephron, 2002, 92(3): 589-600.
|
13. |
中国医院协会血液净化中心管理分会血液净化通路学组. 中国血液透析用血管通路专家共识(第1版). 中国血液净化, 2014, 13(8): 549-558.
|
14. |
Allon M, Brouwer-Maier DJ, Abreo K, et al. Recommended clinical trial end points for dialysis catheters. Clin J Am Soc Nephrol, 2018, 13(3): 495-500.
|
15. |
中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第三版). 中国血管外科杂志(电子版), 2017, 9(4): 250-257.
|
16. |
Green MS, Tellor KB, Buckallew AR. Safety and efficacy of enoxaparin compared with unfractionated heparin for venous thromboembolism prophylaxis in hemodialysis patients. Hosp Pharm, 2017, 52(9): 623-627.
|
17. |
Hollenbeck M, Niehuus A, Wozniak G, et al. Central venous catheters as access for acute and long-term dialysis. Chirurg, 2012, 83(9): 801-808.
|
18. |
李京, 戴晓霞, 张宜默, 等. 血液透析长期中心静脉留置导管功能不良发生率及影响因素分析. 中国血液净化, 2010, 9(4): 178-181.
|
19. |
孙雪峰. 血液透析中合理应用低分子肝素. 中国实用内科杂志, 2008, 28(4): 319-320.
|